Article info
PDFCorrespondence
Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
- Correspondence to Dr Zaixing Yang, Huangyan Hospital of Wenzhou Medical University, Taizhou First People’s Hospital, Taizhou 318002, China; yangzaixingdiyi{at}163.com
Citation
Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
Publication history
- Received May 7, 2019
- Accepted May 9, 2019
- First published May 16, 2019.
Online issue publication
May 15, 2023
Article Versions
- Previous version (15 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.